Articles

San Antonio, TX—A genomic classifier is now available that can predict a low or high risk for metastasis in men with prostate cancer who have rising prostate-specific antigen (PSA) after a prostatectomy. The good news is that this test is reimbursable by Medicare.

Family Patient-Related Factors Main Barriers to End-of-Life Discussions

By Meg Barbor, MPH

End-of-Life Care, Palliative Care, Policies & Guidelines

December 2015, Vol 6, No 11

Boston, MA—Family- and patient-related factors were identified as the most significant barriers to early end-of-life discussions, as well as to the timely discontinuation of cancer-directed therapies in the palliative setting, according to the results of a multicenter survey of oncologists in Ontario, Canada.

American Cancer Society Updates Breast Cancer Screening Guidelines for Women at Average Risk

By Laura Morgan

Breast Cancer, Solid Tumors

December 2015, Vol 6, No 11

Breast cancer is the leading cause of premature death in women. According to the American Cancer Society (ACS), more than 40,000 US women will die of breast cancer in 2015.

Afatinib vs Erlotinib as Second-line Therapy of Patients with Advanced Squamous Cell Carcinoma (SCC) of the Lung: Analysis from the LUX-Lung 8 Trial

Conference Correspondent

CD19-Targeted 19-28z CAR-Modified T-Cells in Adult Patients with Relapsed/Refractory B-Cell ALL: Impact of MRD-Negative CR and Allogeneic Stem-Cell Transplant on Outcomes

ASH 2015 – Leukemia, ASH Highlights

Conference Correspondent

Frontline Inotuzumab Ozogamicin plus Low-Intensity Chemotherapy (mini-hyper-CVD) for Older Patients with ALL

ASH 2015 – Leukemia, ASH Highlights

Conference Correspondent

Dose-Intensified Pegylated-Asparaginase Pediatric Regimen in Adults with Untreated ALL: A DFCI ALL Consortium Phase 2 Trial

ASH 2015 – Leukemia, ASH Highlights

Conference Correspondent

Total Therapy GIMEMA LAL 1509 Protocol for De Novo Adult Ph+ ALL Patients: Updated Results and Genetic-Based Prognostic Stratification